News

Posted On: 05/13/2005

HIRC Finds Pfizer, GSK, Merck, Lilly and Sanofi-Aventis Most Active in Disease Management

Health Industries Research Companies (HIRC), Santa Cruz, Calif., on May 12 released its Spring 2005 Health and Disease Management Service, assessing trends in the disease management (DM) programs of health plans, state Medicaid plans and employers. The Spring 2005 Service details the increasing role that pharmaceutical companies are playing in the development and implementation of programs to manage specific disease states.

Industry Trend

Innovative and successful disease management programs are recognized for offering patient medication compliance, comprehensive patient education and interactive Website tools as key program components. The majority of disease management programs tend to focus on disease states of high cost and high prevalence such as diabetes, asthma and hyperlipidemia.

Statistics At-a-Glance

The Spring 2005 results show that Pfizer leads with health plans with the most disease management offerings across twenty-three different disease states. The top ten firms, based on DM activity, are listed below:

1. Pfizer
2. GlaxoSmithKline
3. Merck
4. Lilly
5. Sanofi-Aventis
6. Wyeth
7. Schering
8. Astra Zeneca
9. Novartis
10. Tie: Novo Nordisk and Roche.

Report Highlights

The Spring 2005 Service focuses on the strategic insight needed to develop successful pharmaceutical marketing plans. Report highlights include:

• Total disease management partnership activity by disease state
  
  
• Perceptual rankings of pharmaceutical disease management programs across Commercial and Medicare health plans, State Medicaid and Employers
  
  
• Pharmaceutical company profiles with disease management programs
  
  
• In-depth disease state profiles
  
  
• Assessments of the most innovative disease management programs
  
  
• Analysis of the disease management program components of most interest to health plans
  
  
• Assessment of Medicare legislation and its impact on disease management programs
  
  
• Rankings of pharmaceutical manufacturers offering Medicare-specific disease management programs

Availability

HIRC publishes the Health and Disease Management Service semi-annually. The Spring 2005 Health and Disease Management Service is available now and includes softbound handbooks, CDs, and downloadable PDF files accessed from the HIRC website. Please note that all HIRC reports are available only to pharmaceutical companies.

About Health Industries Research Companies

Health Industries Research Companies (HIRC) is an independent, nonpartisan organization that conducts strategic market research on a wide variety of health care markets. For more information about HIRC and the company's reports, visit www.hirc.com.